Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease.

J Clin Med · 2022 · PMC9318498 · PMID 35887905

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In this relatively small cohort, we could not show a significant difference in baseline eotaxin-1 levels in UC patients responding to vedolizumab treatment, although we did observe a clear trend towards increased baseline eotaxin-1 levels in responders compared to non-responders.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.